KBC Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.7M Sell
301,508
-202,220
-40% -$18M 0.06% 240
2025
Q4
$39.8M Buy
503,728
+96,924
+24% +$7.6M 0.09% 183
2025
Q3
$32.5M Buy
406,804
+29,960
+8% +$2.56M 0.08% 206
2025
Q2
$34.3M Sell
376,844
-1,342
-0.4% -$123K 0.09% 206
2025
Q1
$35.4M Sell
378,186
-13,582
-3% -$1.22M 0.11% 191
2024
Q4
$35.6M Sell
391,768
-261,867
-40% -$25M 0.1% 204
2024
Q3
$67.9M Sell
653,635
-161,372
-20% -$16.4M 0.21% 99
2024
Q2
$79.1M Buy
815,007
+16,158
+2% +$1.49M 0.24% 80
2024
Q1
$71.9M Sell
798,849
-412,020
-34% -$34.9M 0.23% 95
2023
Q4
$96.5M Buy
1,210,869
+233,163
+24% +$17.5M 0.34% 67
2023
Q3
$69.5M Sell
977,706
-89,959
-8% -$6.73M 0.28% 78
2023
Q2
$82.3M Buy
1,067,665
+205,190
+24% +$15.9M 0.34% 64
2023
Q1
$64.8M Buy
862,475
+66,277
+8% +$4.93M 0.28% 79
2022
Q4
$62.7M Buy
796,198
+458,840
+136% +$34.4M 0.3% 75
2022
Q3
$23.7M Sell
337,358
-93,616
-22% -$7.34M 0.12% 182
2022
Q2
$34.5M Buy
430,974
+136,279
+46% +$10.7M 0.17% 142
2022
Q1
$22.3M Sell
294,695
-26,708
-8% -$2.12M 0.09% 226
2021
Q4
$27.4M Sell
321,403
-203,844
-39% -$15.9M 0.09% 224
2021
Q3
$39.7M Sell
525,247
-715,581
-58% -$56.8M 0.15% 169
2021
Q2
$101M Sell
1,240,828
-27,314
-2% -$2.23M 0.18% 133
2021
Q1
$100M Buy
1,268,142
+74,708
+6% +$5.86M 0.2% 121
2020
Q4
$561M Buy
1,193,434
+211,714
+22% +$17.5M 0.24% 103
2020
Q3
$75.7M Buy
981,720
+117,470
+14% +$8.96M 0.22% 106
2020
Q2
$63.3M Buy
864,250
+258,225
+43% +$18.3M 0.21% 114
2020
Q1
$40.2M Buy
606,025
+305,370
+102% +$21.5M 0.34% 64
2019
Q4
$20.7M Buy
300,655
+16,851
+6% +$1.15M 0.13% 195
2019
Q3
$20.9M Sell
283,804
-98,805
-26% -$7.17M 0.15% 164
2019
Q2
$27.4M Buy
382,609
+93,711
+32% +$6.65M 0.21% 120
2019
Q1
$19.8M Buy
288,898
+101,839
+54% +$6.58M 0.16% 161
2018
Q4
$11.1M Sell
187,059
-63,319
-25% -$3.96M 0.12% 207
2018
Q3
$16.8M Buy
250,378
+78,873
+46% +$5.25M 0.13% 208
2018
Q2
$11.1M Buy
171,505
+29,332
+21% +$1.92M 0.1% 263
2018
Q1
$10.2M Sell
142,173
-49,766
-26% -$3.58M 0.09% 255
2017
Q4
$14.5M Sell
191,939
-5,165
-3% -$377K 0.12% 206
2017
Q3
$14.4M Buy
197,104
+51,561
+35% +$3.72M 0.13% 188
2017
Q2
$10.8M Sell
145,543
-6,790
-4% -$504K 0.1% 240
2017
Q1
$11.2M Buy
152,333
+38,471
+34% +$2.69M 0.1% 248
2016
Q4
$7.45M Sell
113,862
-75,199
-40% -$5.16M 0.07% 316
2016
Q3
$14M Sell
189,061
-9,689
-5% -$716K 0.17% 152
2016
Q2
$14.5M Buy
198,750
+59,887
+43% +$4.26M 0.21% 127
2016
Q1
$9.81M Buy
138,863
+62,088
+81% +$4.13M 0.16% 164
2015
Q4
$5.12M Sell
76,775
-9,517
-11% -$633K 0.09% 254
2015
Q3
$5.47M Sell
86,292
-2,658
-3% -$174K 0.11% 232
2015
Q2
$5.82M Buy
88,950
+17,860
+25% +$1.21M 0.08% 300
2015
Q1
$4.93M Sell
71,090
-32,261
-31% -$2.23M 0.06% 311
2014
Q4
$7.15M Buy
103,351
+37,826
+58% +$2.55M 0.09% 278
2014
Q3
$4.27M Sell
65,525
-1,060
-2% -$69.9K 0.15% 189
2014
Q2
$4.54M Sell
66,585
-32,557
-33% -$2.18M 0.05% 404
2014
Q1
$6.43M Buy
99,142
+12,981
+15% +$818K 0.1% 242
2013
Q4
$5.62M Sell
86,161
-37,101
-30% -$2.37M 0.09% 293
2013
Q3
$7.31M Sell
123,262
-69,249
-36% -$4.1M 0.12% 232
2013
Q2
$11M Buy
+192,511
New +$11.4M 0.2% 120

Other funds holding CL

KBC Group's CL Position: Q1 2026 in Review

KBC Group reduced its Colgate-Palmolive (CL) stake by 40% in Q1 2026, selling an estimated $18M and leaving 301,508 shares worth $25.7M. The position accounts for 0.06% of the portfolio, ranked #240.

KBC Group first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $561M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • KBC Group held 301,508 shares of Colgate-Palmolive worth $25.7M as of Q1 2026.
  • KBC Group sold 202,220 Colgate-Palmolive shares in Q1 2026, an estimated $18M.
  • Colgate-Palmolive made up 0.06% of KBC Group's portfolio in Q1 2026, its #240 holding.
  • KBC Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Colgate-Palmolive position peaked at $561M in Q4 2020.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.